Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
136 hedge funds and large institutions have $842M invested in Intersect ENT, Inc in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 20 closing their positions.
352% more call options, than puts
Call options by funds: $8.87M | Put options by funds: $1.96M
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
20% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 45
4% more capital invested
Capital invested by funds: $808M → $842M (+$34.2M)
1% less funds holding
Funds holding: 138 → 136 (-2)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$19.5M |
| 2 |
HM
HealthCor Management
New York
|
+$15.8M |
| 3 |
Man Group
London,
United Kingdom
|
+$9.41M |
| 4 |
Millennium Management
New York
|
+$6.61M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$6.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadian Capital Management
New York
|
-$9.62M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.77M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.24M |
| 4 |
BlackRock
New York
|
-$4.28M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$4.25M |
XENT Hedge Fund Activity: Q4 2018 in Review
136 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2018, worth a combined $842M — up 4.2% from $808M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of XENT and 18 opened new positions — a net loss of 2 holders — while 45 trimmed existing stakes and 54 added.
The largest buyer was Waddell & Reed Financial, adding an estimated $19.5M. The largest seller was Cadian Capital Management, exiting entirely with an estimated $9.62M sold.
- 136 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2018, down from 138 in Q3 2018.
- Funds reported $842M of Intersect ENT, Inc stock for Q4 2018, up 4.2% quarter-over-quarter.
- 18 funds opened new Intersect ENT, Inc positions in Q4 2018 and 20 closed out, a net change of -2 holders.
- The largest Intersect ENT, Inc buyer in Q4 2018 was Waddell & Reed Financial, an estimated $19.5M added.
- The largest Intersect ENT, Inc seller in Q4 2018 was Cadian Capital Management, an estimated $9.62M sold.
Based on aggregated 13F filings for Q4 2018.